Analysts estimate the cost of debt capital for Abbott Laboratories $($NYSE: ABT$)$ is $2\mathrm{.}13\%$ and that its cost of equity capital is $4\mathrm{.}1\%.$ Assume that ABT's marginal tax rate is $36\%,$ the risk$-$free rate is $5\mathrm{.}3\%,$ the market risk premium is $5\mathrm{.}7\%,$ the ABT market price is $$47\mathrm{.}73$ per common share, and its dividends are $$1\mathrm{.}26$ per common share.